SF3B2 and colorectal carcinoma: Multivariate Cox regression analysis showed that high SF3B2 expression was an independent predictor of poor survival of CRC patients (RR, 1.903; 95% CI, 1.258–2.879; P = 0.002) (Supplementary Table 3).